BC Partners has carved out Netherlands-based Synthon International, a pharmaceutical company specialising in the development and distribution of complex generics, from its parent company Synthon Holding.
GP intends to boost the company's expansion internationally, primarily in Asia, the Middle East and the US
VCs invested in the nanobodies developer in 2010; ChromoTek has been sold to a US-based market peer
Previously a portfolio company of Hg 6, Iris is now owned by Hg Saturn Fund, which closed on £1.5bn
Claire Heuberger will join the joint venture and partnering group, and will be based in Brussels